Staff Writer

ICER Report on Lecanemab: Efficacy, Cost, and Equity Concerns for Alzheimer&#...
Update on the HTA Coordination Group subgroup meetings held on April 25 and 26
New Preferred Characteristics for Monoclonal Antibodies in Malaria Prevention
Tezepelumab as an Add-on Maintenance Treatment for Severe Asthma: Recommendat...
Clinical evidence shows that AposHealth (an FDA-cleared medical device) impro...
Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Go...